Nonspecific crossreacting antigen (NCA) is a major member of the carcinoembryonic antigen (CEA)-related gene family expressed in lung cancer.
Carcinoembryonic antigen (CEA) is one of the most important tumour markers in the management of human carcinoma, including lung cancer. So far, however, because of the nonspecificity of anti-CEA antibodies, it remains unclear whether the experimental measurements of CEA expression really reflect gen...
Main Authors: | Hasegawa, T., Isobe, K., Tsuchiya, Y., Oikawa, S., Nakazato, H., Nakashima, I., Shimokata, K. |
---|---|
Format: | Online |
Language: | English |
Published: |
1993
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968238/ |
Similar Items
-
Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation.
by: Kodera, Y., et al.
Published: (1993) -
A monkey antigen crossreacting with carcinoembryonic antigen, CEA.
by: Engvall, E., et al.
Published: (1976) -
Establishment and characterisation of human carcinoembryonic antigen transgenic mice.
by: Hasegawa, T., et al.
Published: (1991) -
Study of the antigenic cross reactivity between carcinoembryonic antigen and "nonspecific cross reacting antigens" (NCA and NCA 2).
by: Neveu, T., et al.
Published: (1975) -
Carcinoembryonic antigen (CEA) "fingerprints".
by: Rule, A. H., et al.
Published: (1973)